Thermo Fisher Scientific To Distribute Synthego’s Synthetic Guide RNA Products For CRISPR Genome Engineering

Scientist To Distribute Synthego’s Guide RNA Products For CRISPR

A leading provider of genome engineering solutions, Synthego, has now announced a new alignment with Thermo Fisher Scientific to manufacture and distribute world-class quality synthetic guide RNA products. Synthego’s synthetic guide RNA portfolio and industry-leading synthetic guide RNA manufacturing capabilities will be utilized to produce synthetic guide RNAs under Thermo Fisher’s Invitrogen TrueGuide brand that will be marketed and sold across Thermo Fisher channels worldwide.

In use by leading commercial and academic institutions in over 32 countries, Synthego’s synthetic guide RNAs achieve up to 90% editing efficiency, and have one of the lowest costs and turnaround times in the industry. Synthego currently sells its products online and through its direct salesforce. By providing access through the global Thermo Fisher channels, Synthego rapidly scales commercial efforts across markets worldwide.

Synthetic guide RNA products available under the Thermo Fisher Scientific TrueGuide brand include synthetic crRNA:tracrRNA, synthetic single guide RNA (sgRNA), and chemically modified sgRNA. The products, available for research use only and marketed under Invitrogen’s TrueGuide brand, may differ from those sold by Synthego in configuration and design. Synthego’s own products will continue to be available directly to customers.

“With Thermo Fisher’s reputation and extensive market reach, this partnership will make high-quality synthetic guide RNA technologies for CRISPR genome engineering readily accessible to all scientists worldwide,

“Synthego’s manufacturing capabilities for synthetic guide RNAs are ideal to produce Thermo Fisher’s TrueGuide synthetic gRNAs,” added Helge Bastian, Thermo Fisher’s vice president and general manager of synthetic biology. “With the addition of TrueGuide synthetic gRNAs, Invitrogen’s TrueEdit portfolio now provides end-to-end solutions for researchers’ genome editing applications.“